How can Human Hsp70 Disaggregase potentially reverse Parkinson's-linked α-Synuclein amyloid fibrils, given the need for therapeutic agents to address neurodegenerative disorders caused by protein misfolding and aggregation, and the role of disaggregases in resolubilizing protein aggregates?
['["Therapeutic agents are urgently required to cure several common and fatal neurodegenerative disorders caused by protein misfolding and aggregation, including amyotrophic lateral sclerosis (ALS), Parkinson\'s disease (PD), and Alzheimer\'s disease (AD).", "Human Hsp70 Disaggregase Reverses Parkinson\'s-Linked \\u03b1-Synuclein Amyloid Fibrils.", "Disaggregases, molecular chaperones that resolubilize protein aggregates.", "The structural basis by which Hsp104 dissolves disordered aggregates and prions is unknown."]']
Human Hsp70 Disaggregase can potentially reverse Parkinson's-linked α-Synuclein amyloid fibrils by resolubilizing protein aggregates. Disaggregases, such as Hsp70, are molecular chaperones that can dissolve protein aggregates, including those linked to neurodegenerative disorders like Parkinson's disease. This process is crucial in addressing the protein misfolding and aggregation that underlie conditions such as ALS, PD, and AD.
[]